INmune Bio
INMB
INMB
78 hedge funds and large institutions have $12.7M invested in INmune Bio in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
60% less call options, than puts
Call options by funds: $4.21M | Put options by funds: $10.5M
74% less capital invested
Capital invested by funds: $48.1M → $12.7M (-$35.4M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
78
Holding in Top 10
–
Calls
$4.21M
Puts
$10.5M
Top Buyers
| 1 | +$721K | |
| 2 | +$518K | |
| 3 | +$205K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$154K |
| 5 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
+$147K |
Top Sellers
| 1 | -$6.76M | |
| 2 | -$1.84M | |
| 3 | -$793K | |
| 4 |
PHS
Pekin Hardy Strauss
Chicago,
Illinois
|
-$736K |
| 5 |
Millennium Management
New York
|
-$459K |
